| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | KNSA Kiniksa Pharmaceuticals International, Plc | Quart Barry D | Director | Sell | 21,959 | $16.15 | $354,637.85 | -100% | -17.2% | -1.7% | |
| Nov 29, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 52,900 | $3.04 | $160,555.62 | +4.2% | -30.7% | -35.3% | |
| Nov 28, 2022 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 43 | $22.00 | $946.00 | - | +24.9% | +18.9% | |
| Nov 28, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $268.67 | $4,298,654.20 | -71.4% | -8.8% | -14.9% | |
| Nov 25, 2022 | LFCR Lifecore Biomedical, Inc. \de\ | Wynnefield Partners Small Cap Value LP I65 | 10% Owner | Buy | 627,746 | $7.97 | $5,003,135.62 | +16.6% | -28.6% | -10.3% | |
| Nov 25, 2022 | ETST Earth Science Tech, Inc. | Saumat Giorgio R. | Director, 10% Owner | Buy | 20,000 | $0.04 | $800.00 | - | - | - | |
| Nov 25, 2022 | EBS Emergent Biosolutions Inc. | Richard Ronald | Director | Sell | 1,912 | $11.94 | $22,829.28 | -8.8% | +20.2% | -82.4% | |
| Nov 25, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 13,394 | $35.16 | $470,873.55 | -0.8% | +9.6% | -21.0% | |
| Nov 25, 2022 | VTRS Viatris Inc | Ni Xiangyang (sean)50 | President, Greater China | Sell | 12,800 | $10.95 | $140,220.16 | -30.5% | +3.6% | -15.4% | |
| Nov 23, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $268.42 | $4,294,728.09 | -34.3% | -4.4% | -13.4% | |
| Nov 23, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 53,300 | $3.04 | $161,828.01 | +4.5% | -28.7% | -33.2% | |
| Nov 22, 2022 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 65 | $22.00 | $1,430.00 | - | +18.2% | +18.4% | |
| Nov 22, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 600 | $35.00 | $21,001.08 | - | +11.1% | -21.5% | |
| Nov 22, 2022 | JNJ Johnson & Johnson | Taubert Jennifer L60 | EVP, Ww Chair, Pharmaceuticals | Sell | 76,923 | $176.78 | $13,598,401.79 | -37.8% | -10.6% | -14.7% | |
| Nov 22, 2022 | AVDL Avadel Pharmaceuticals Plc | Ende Eric J81 | Director | Buy | 20,000 | $7.80 | $156,050.00 | +14.8% | +1.3% | +43.2% | |
| Nov 21, 2022 | IRWD Ironwood Pharmaceuticals Inc | Silver Ronald68 | Principal Accounting Officer | Sell | 682 | $11.56 | $7,883.92 | -0.6% | +1.7% | -18.2% | |
| Nov 21, 2022 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Sell | 531 | $35.01 | $18,592.22 | - | +12.1% | -21.4% | |
| Nov 21, 2022 | IRWD Ironwood Pharmaceuticals Inc | Davis Andrew73 | SVP, Chief Business Officer | Sell | 3,335 | $11.56 | $38,552.60 | -2.1% | +1.7% | -18.2% | |
| Nov 21, 2022 | IRWD Ironwood Pharmaceuticals Inc | Emany Sravan Kumar47 | SVP, Chief Financial Officer | Sell | 6,578 | $11.56 | $76,041.68 | -7.7% | +1.7% | -18.2% | |
| Nov 21, 2022 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 16,000 | $265.45 | $4,247,239.17 | -22.5% | -3.9% | -13.2% | |
| Nov 21, 2022 | ORGO Organogenesis Holdings Inc. | Katz Michael W | 10% Owner | Buy | 6,000 | $2.57 | $15,390.00 | +4.2% | -6.9% | -1.5% | |
| Nov 18, 2022 | JNJ Johnson & Johnson | Decker Robert J56 | Controller, CAO | Sell | 16,928 | $175.00 | $2,962,400.00 | -52.2% | -9.6% | -14.4% | |
| Nov 18, 2022 | PBH Prestige Consumer Healthcare Inc. | Lombardi Ronald M.52 | Chief Executive Officer | Sell | 38,793 | $59.10 | $2,292,569.32 | -14.9% | +1.7% | -2.4% | |
| Nov 18, 2022 | COLL Collegium Pharmaceutical, Inc | Ciaffoni Joseph | President And CEO | Sell | 1,989 | $22.02 | $43,797.78 | -0.6% | +21.3% | +14.8% | |
| Nov 18, 2022 | CRON Cronos Group Inc. | Adler Jason Marc49 | Director | Buy | 110,400 | $2.96 | $327,243.30 | +11.2% | -26.3% | -37.2% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.